- Dextromethorphan/quinidine in migraine prophylaxis: An open-label observational clinical study
- Phase II study of crizotinib in East Asian patients with ROS1-positive advanced non–small-cell lung cancer
- Long-term retention of adalimumab treatment and associated prognostic factors for 1,189 patients with Crohn's disease
- Nivolumab for relapsed/refractory classic Hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: Extended follow-up of the multicohort single-arm phase II CheckMate 205 trial
- Ibrutinib plus venetoclax for the treatment of mantle-cell lymphoma
- Rituximab vs the modified ponticelli regimen in the treatment of primary membranous nephropathy: A health economic model
- Comparison of effects of anagliptin and alogliptin on serum lipid profile in type 2 diabetes mellitus patients
- Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: A systematic review and meta-analysis
- Bivalirudin vs heparin with primary percutaneous coronary intervention
- Switching from abacavir to tenofovir disoproxil fumarate is associated with rises in soluble glycoprotein VI, suggesting changes in platelet–collagen interactions
- Prospective international randomized phase II study of low-dose abiraterone with food vs standard dose abiraterone in castration-resistant prostate cancer
- Valganciclovir is beneficial in children with congenital cytomegalovirus and isolated hearing loss
- A randomized double-blind placebo-controlled study comparing intracoronary vs intravenous abciximab in patients with ST-elevation myocardial infarction undergoing transradial rescue percutaneous coronary intervention after failed thrombolysis
- The effects of an oral taurine dose and supplementation period on endurance exercise performance in humans: A meta-analysis
- What non-carbapenem antibiotics are active against ESBL-producing <em>Enterobacteriaceae</em>?
Feed Sources
